Dirk plugs Benitec!, page-16

Looking fwd to the local market no longer driving this stock. Those who are behind it are in, and those unsure are driving the pricing. Taking their lead today off the individual with his sub 70c sell order off 900 shares.

Stepping back a bit, gene therapy and RNAi are growth areas. Competitor sp appreciation in US makes this obvious and beyond debate. Benitec is well positioned to lever into this growth.

Under capitalisation would be the big mistake, but for some reason we've gone all brown cardigan CPA on this. Not the time to do that. Wait until it's got Alny or CSL mc for that.